Isaac Kinde Selected Research

Neoplasms (Cancer)

1/2019	Targeted sequencing of plasmacytoid urothelial carcinoma reveals frequent TERT promoter mutations.
1/2018	Non-invasive detection of urothelial cancer through the analysis of driver gene mutations and aneuploidy.
1/2018	Detection of aneuploidy in patients with cancer through amplification of long interspersed nucleotide elements (LINEs).
1/2018	Evaluation of liquid from the Papanicolaou test and other liquid biopsies for the detection of endometrial and ovarian cancers.
1/2016	Diagnostic potential of tumor DNA from ovarian cyst fluid.
1/2016	Detection of TERT promoter mutations in primary adenocarcinoma of the urinary bladder.
8/2015	Detection of tumor-derived DNA in cerebrospinal fluid of patients with primary tumors of the brain and spinal cord.
11/2014	Detection of somatic TP53 mutations in tampons of patients with high-grade serous ovarian cancer.
2/2014	Detection of circulating tumor DNA in early- and late-stage human malignancies.
1/2014	Association of the autoimmune disease scleroderma with an immunologic response to cancer.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Isaac Kinde Research Topics

Disease

15	Neoplasms (Cancer) 01/2019 - 02/2010
4	Carcinoma (Carcinomatosis) 01/2019 - 12/2013
3	Ovarian Neoplasms (Ovarian Cancer) 01/2018 - 01/2013
2	Endometrial Neoplasms (Endometrial Cancer) 01/2018 - 01/2013
1	Colorectal Neoplasms (Colorectal Cancer) 08/2019
1	Rectal Neoplasms (Rectal Cancer) 01/2019
1	Sarcoma (Soft Tissue Sarcoma) 01/2019
1	Colonic Neoplasms (Colon Cancer) 01/2016
1	Residual Neoplasm 01/2016
1	Ovarian Cysts (Ovarian Cyst) 01/2016
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2016
1	Adenocarcinoma 01/2016
1	Spinal Cord Neoplasms (Spinal Cord Tumors) 08/2015
1	Circulating Neoplastic Cells 02/2014
1	Connective Tissue Diseases (Connective Tissue Disease) 01/2014
1	Autoimmune Diseases (Autoimmune Disease) 01/2014
1	Glioma (Gliomas) 01/2014
1	Urinary Bladder Neoplasms (Bladder Cancer) 12/2013
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2013
1	Breast Neoplasms (Breast Cancer) 11/2012
1	Aneuploidy (Aneuploid) 01/2012
1	Down Syndrome (Down's Syndrome) 01/2012

Drug/Important Bio-Agent (IBA)

10	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 01/2012
5	Circulating Tumor DNAIBA 08/2019 - 11/2012
5	Biomarkers (Surrogate Marker)IBA 01/2019 - 02/2010
3	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2019 - 12/2013
2	Cell-Free Nucleic AcidsIBA 08/2015 - 11/2012
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	Cadherins (E-Cadherin)IBA 01/2019
1	Troleandomycin (TAO)FDA Link 01/2018
1	Formaldehyde (Formol)FDA Link 01/2016
1	ParaffinIBA 01/2016
1	AutoantigensIBA 01/2014
1	AntigensIBA 01/2014
1	AntibodiesIBA 01/2014
1	Histones (Histone)IBA 01/2014
1	NucleotidesIBA 01/2014
1	Indicators and Reagents (Reagents)IBA 12/2013

Therapy/Procedure

2	Cystectomy 01/2016 - 01/2016
1	Adjuvant Chemotherapy 01/2019
1	Menstrual Hygiene Products (Menstrual Pad) 11/2014